Integra LifeSciences Holdings Corporation – NASDAQ:IART
Integra LifeSciences Holdings stock price today
$14.7
-7.62
-34.17%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market open
Closed in about 3 hours
Integra LifeSciences Holdings stock price monthly change
-25.59%
month
Integra LifeSciences Holdings stock price quarterly change
-25.59%
quarter
Integra LifeSciences Holdings stock price yearly change
-49.11%
year
Integra LifeSciences Holdings key metrics
Market Cap | 1.68B |
Enterprise value | 6.03B |
P/E | 26.88 |
EV/Sales | 3.87 |
EV/EBITDA | 15.81 |
Price/Sales | 3.13 |
Price/Book | 2.70 |
PEG ratio | 2.91 |
EPS | 0.49 |
Revenue | 1.52B |
EBITDA | 179.55M |
Income | 40.23M |
Revenue Q/Q | -3.14% |
Revenue Y/Y | -2.06% |
Profit margin | 11.59% |
Oper. margin | 15.34% |
Gross margin | 62.29% |
EBIT margin | 15.34% |
EBITDA margin | 11.74% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeIntegra LifeSciences Holdings stock price history
Integra LifeSciences Holdings stock forecast
Integra LifeSciences Holdings financial statements
| Jun 2023 | 381.26M | 4.18M | 1.1% |
|---|---|---|---|
| Sep 2023 | 382.42M | 19.49M | 5.1% |
| Dec 2023 | 397.03M | 19.83M | 5% |
| Mar 2024 | 368.87M | -3.28M | -0.89% |
| Mar 2024 | 368.87M | -3.28M | -0.89% |
|---|---|---|---|
| Sep 2025 | 439.01M | 74.85M | 17.05% |
| Oct 2025 | 446.34M | 68.22M | 15.29% |
| Dec 2025 | 468.86M | 78.33M | 16.71% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 3777601000 | 2.09B | 55.44% |
|---|---|---|---|
| Sep 2023 | 3739371000 | 2.16B | 57.77% |
| Dec 2023 | 3781988000 | 2.19B | 58.01% |
| Mar 2024 | 4078224000 | 2.48B | 60.82% |
| Jun 2023 | 28.27M | -15.54M | -10.69M |
|---|---|---|---|
| Sep 2023 | 26.77M | -7.69M | -49.65M |
| Dec 2023 | 58.75M | -57.22M | -6.89M |
| Mar 2024 | 15.75M | -53.96M | 358.67M |
Integra LifeSciences Holdings alternative data
| Aug 2023 | 3,722 |
|---|---|
| Sep 2023 | 3,722 |
| Oct 2023 | 3,722 |
| Nov 2023 | 3,722 |
| Dec 2023 | 3,722 |
| Jan 2024 | 3,722 |
| Feb 2024 | 3,722 |
| Mar 2024 | 3,946 |
| Apr 2024 | 3,946 |
| May 2024 | 3,946 |
| Jun 2024 | 3,946 |
| Jul 2024 | 3,946 |
Integra LifeSciences Holdings other data
76.61%
-9.37%
of IART is owned by hedge funds
246
-23
64.06M
-8.39M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Mar 2024 | 0 | 8348 |
| May 2024 | 88991 | 0 |
| Aug 2024 | 0 | 1191 |
| Dec 2024 | 0 | 5770 |
| Quarter | Transcript |
|---|---|
| Q1 2024 6 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 28 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 25 Oct 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 27 Jul 2023 | Q2 2023 Earnings Call Transcript |
-
What's the price of Integra LifeSciences Holdings stock today?
One share of Integra LifeSciences Holdings stock can currently be purchased for approximately $14.7.
-
When is Integra LifeSciences Holdings's next earnings date?
Unfortunately, Integra LifeSciences Holdings's (IART) next earnings date is currently unknown.
-
Does Integra LifeSciences Holdings pay dividends?
No, Integra LifeSciences Holdings does not pay dividends.
-
How much money does Integra LifeSciences Holdings make?
Integra LifeSciences Holdings has a market capitalization of 1.68B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 1.03% to 1.54B US dollars.
-
What is Integra LifeSciences Holdings's stock symbol?
Integra LifeSciences Holdings Corporation is traded on the NASDAQ under the ticker symbol "IART".
-
What is Integra LifeSciences Holdings's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Integra LifeSciences Holdings?
Shares of Integra LifeSciences Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Integra LifeSciences Holdings's key executives?
Integra LifeSciences Holdings's management team includes the following people:
- Mr. Glenn G. Coleman Executive Vice President & Chief Operating Officer(age: 57, pay: $927,950)
- Ms. Carrie L. Anderson Executive Vice President, Chief Financial Officer & Treasurer(age: 56, pay: $810,710)
- Mr. Robert T. Davis Jr. Executive Vice President and Pres of Orthopedics & Tissue Technologies(age: 66, pay: $675,510)
-
How many employees does Integra LifeSciences Holdings have?
As Jul 2024, Integra LifeSciences Holdings employs 3,946 workers.
-
When Integra LifeSciences Holdings went public?
Integra LifeSciences Holdings Corporation is publicly traded company for more then 30 years since IPO on 16 Aug 1995.
-
What is Integra LifeSciences Holdings's official website?
The official website for Integra LifeSciences Holdings is integralife.com.
-
Where are Integra LifeSciences Holdings's headquarters?
Integra LifeSciences Holdings is headquartered at 1100 Campus Road, Princeton, NJ.
-
How can i contact Integra LifeSciences Holdings?
Integra LifeSciences Holdings's mailing address is 1100 Campus Road, Princeton, NJ and company can be reached via phone at +60 9 275 0500.
Integra LifeSciences Holdings company profile:
Integra LifeSciences Holdings Corporation
integralife.comExchange:
NASDAQ
Full time employees:
3,946
Industry:
Medical - Devices
Sector:
Healthcare
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
1100 Campus Road
Princeton, NJ 08540
Princeton, NJ 08540
CIK: 0000917520
ISIN: US4579852082
CUSIP: 457985208
